Twist Bioscience rises as Q4 rev beats estimates

Twist Bioscience

17/11/2023 14:13

** Shares of Twist Bioscience Corp  TWST.O  rises 7.5% to
$20.5 premarket
    ** Co reports Q4 rev at $67.0 mln vs. Wall Street estimates
of $63.5 mln - LSEG
    ** TWST's Q4 loss narrows to 81 cents/shr vs. a loss of 91
cents/shr year-ago
    ** Co sees FY24 rev between $285 mln and $290 mln vs. avg.
estimates of $298.7 mln - LSEG
    ** 8 of 11 brokerages rate the stock "buy" or higher, 2
"hold" and 1 "sell"; their median PT is $26
    ** Up to Thursday's close, stock was down 20% YTD vs. a 11%
decline in the Nasdaq Biotechnology Index  .NBI 

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))